Similar articles for PMID: 19124053

Year	Number of Results
2002	1
2003	2
2004	7
2005	7
2006	5
2007	7
2008	12
2009	9
2010	3
2011	5
2012	6
2013	2
2014	6
2015	9
2016	2
2017	1
2018	5
2019	5
2024	0

1

Purification and structural analyses of ABCG2.

McDevitt CA, Collins R, Kerr ID, Callaghan R. McDevitt CA, et al. Adv Drug Deliv Rev. 2009 Jan 31;61(1):57-65. doi: 10.1016/j.addr.2008.07.004. Epub 2008 Dec 13. Adv Drug Deliv Rev. 2009. PMID: 19124053 Review.

2

Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Ni Z, Bikadi Z, Rosenberg MF, Mao Q. Ni Z, et al. Curr Drug Metab. 2010 Sep;11(7):603-17. doi: 10.2174/138920010792927325. Curr Drug Metab. 2010. PMID: 20812902 Free PMC article. Review.

3

Detergent-free purification of ABC (ATP-binding-cassette) transporters.

Gulati S, Jamshad M, Knowles TJ, Morrison KA, Downing R, Cant N, Collins R, Koenderink JB, Ford RC, Overduin M, Kerr ID, Dafforn TR, Rothnie AJ. Gulati S, et al. Biochem J. 2014 Jul 15;461(2):269-78. doi: 10.1042/BJ20131477. Biochem J. 2014. PMID: 24758594

4

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499. Cancer Res. 2008. PMID: 18829547 Free PMC article.

5

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Fan YF, Zhang W, Zeng L, Lei ZN, Cai CY, Gupta P, Yang DH, Cui Q, Qin ZD, Chen ZS, Trombetta LD. Fan YF, et al. Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11. Cancer Lett. 2018. PMID: 29331420

6

Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.

Ejendal KF, Hrycyna CA. Ejendal KF, et al. Curr Protein Pept Sci. 2002 Oct;3(5):503-11. doi: 10.2174/1389203023380521. Curr Protein Pept Sci. 2002. PMID: 12369998 Review.

7

Role of the breast cancer resistance protein (ABCG2) in drug transport.

Mao Q, Unadkat JD. Mao Q, et al. AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112. AAPS J. 2005. PMID: 16146333 Free PMC article.

8

Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.

McDevitt CA, Collins RF, Conway M, Modok S, Storm J, Kerr ID, Ford RC, Callaghan R. McDevitt CA, et al. Structure. 2006 Nov;14(11):1623-32. doi: 10.1016/j.str.2006.08.014. Structure. 2006. PMID: 17098188 Free article.

9

Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.

Xu J, Liu Y, Yang Y, Bates S, Zhang JT. Xu J, et al. J Biol Chem. 2004 May 7;279(19):19781-9. doi: 10.1074/jbc.M310785200. Epub 2004 Mar 4. J Biol Chem. 2004. PMID: 15001581 Free article.

10

Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.

Shukla S, Robey RW, Bates SE, Ambudkar SV. Shukla S, et al. Drug Metab Dispos. 2009 Feb;37(2):359-65. doi: 10.1124/dmd.108.024612. Epub 2008 Oct 29. Drug Metab Dispos. 2009. PMID: 18971320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year